Background/Aims: To determine the cellular functions and clinical significance of micro-758-5p (miR-758-5p) in glioblastoma (GBM) by targeting zinc finger and BTB domain-containing protein 20 (ZBTB20). Methods: Fifty-five paired GBM tissues and adjacent normal tissues, GBM cell lines (U118, LN-299, H4, A172, U87-MG, and U251), and normal human astrocyte cell line (HEB) were used. miR-758-5p mimics, ZBTB20 siRNA, and pcDNA3.1-ZBTB20 were transiently transduced into cancer cells independently or together. qRT-PCR was conducted to analyze the expression of miR-758-5p and ZBTB20. Luciferase reporter assays were performed to determine the effect of miR-758-5p on ZBTB20. Western blot was applied to measure the expression of ZBTB20, PCNA, and cleaved caspase3. Cell Counting Kit-8 (CCK8), colony formation, FACS, and Transwell assays were carried out to detect cellular proliferation, apoptosis, migration, and invasion. Xenograft experiments were implemented to evaluate tumor growth and metastasis in vivo. Results: miR-758-5p was significantly downregulated in GBM tissues and cell lines compared with that in adjacent normal tissues and HEB cells. miR-758-5p overexpression inhibited the proliferation, migration, and invasion of GBM cells and induced apoptosis by regulating the ZBTB20 expression. Pearson correlation analysis also confirmed that miR-758-5p was inversely correlated with ZBTB20 in GBM tissues. miR-758-5p suppressed tumor growth and metastasis in vivo. The restored ZBTB20 expression partially rescued the miR-758-5p-induced inhibition of GBM cell proliferation, migration, and invasion. Kaplan-Meier curve analysis revealed that a high miR-758-5p expression indicated an enhanced prognosis of patients with GBM. Conclusion: miR-758-5p suppressed GBM progression by targeting ZBTB20. The miR-758-5p/ZBTB20 axis might be a promising therapeutic target for GBM treatment.
Introduction
As a lethal malignant tumor, glioblastoma (GBM) is the most common primary brain tumor [1] . Although GBM therapy has remarkably improved, early diagnosis remains difficult. As the most commonly used method, surgical resection followed by concomitant chemoradiation for GBM treatment is inefficient [2, 3] . The median survival of 14.6 months is low [4, 5] . As such, the mechanisms of the progression of this complicated disease should be understood, and new treatment methods should be developed.
MicroRNAs (miRNAs) are a new class of highly conserved non-protein-encoding small molecules that regulate gene expression through an miR-RISC complex [6] . With the binding of miR-RISC complex to the 3ʹuntranslated region (UTR) of target mRNAs, target gene expression is usually suppressed [7] . miRNAs play an important role in a wide range of biological processes, including cell proliferation, apoptosis, and cancer progression [8] [9] [10] . Human miRNA genes are frequently found co-localized with genomic regions involved in cancer [11] . These genes also have altered expression in different types of human cancers. Therefore, miRNAs may serve as biomarkers for cancer diagnosis, prognosis, and pathogenesis [12, 13] .
Studies have shown the functions of miRNAs in GBM. More than 300 miRNAs are differently regulated in GBM compared with that in normal tissues [14] , and their expression is usually correlated with various glioma stages [15, 16] . miRNAs regulate the proliferation, differentiation, and apoptosis of GBM [17] [18] [19] . To further study the role of miRNAs in GBM progression, we conducted an unbiased analysis of the GBM database and found that miR-758-5p was downregulated in GBM tissues. miR-758-5p participates in cholesterol uptake [20] and possibly functions in cancer progression [21, 22] , but its role in GBM has yet to be investigated. In this study, we found that miR-758-5p acted as a GBM suppressor gene, suppressed GBM cell proliferation, invasion, and migration, and induced GBM apoptosis. miR-758-5p mechanically bound to the 3ʹUTR of ZBTB20, inhibited ZBTB20 expression, and further suppressed GBM progression.
Materials and Methods

Human samples
Paraffin-embedded tumor specimens from 55 cases were surgically collected from The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University. The diagnosis of GBM in these cases was confirmed through a pathological examination. All of the patients in this study did not receive chemotherapy or radiotherapy before they underwent surgical excision. In addition, 55 cases of normal brain tissues (nontumor tissues) were obtained as a control. All of the patients provided a signed informed consent. Our study was approved by the ethics committee of The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University.
Cell culture HEB was purchased from the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences. U118, LN-299, H4, A172, and U87-MG were procured from the American Type Culture Collection (ATCC, USA). U251 cell was obtained from Cell Lines Service (CLS, Germany). All of the cells were maintained in DMEM (Gibco, Thermo Scientific, New York, NY, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Scientific, New York, NY, USA) and 1% sodium pyruvate and cultured at 37 °C in 5% CO 2 .
miR-758-5p mimics, negative control, and ZBTB20 siRNA were synthesized by GenePharma (Shanghai, China), and Lipofectamine 2000 (Invitrogen, USA) was used to transfect genes into cells.
Quantitative real-time polymerase chain reaction (qRT-PCR)
RNA was extracted using Trizol reagent (Thermo Fisher Scientific, USA) in accordance with the manufacturer's instructions. Total mRNA (1 μg) was reverse transcribed into cDNA with SuperScript™ III First-strand Synthesis System (Thermo Fisher Scientific, USA). RT-qPCR was performed with SYBR Green Real-time PCR Master Mixes (Thermo Fisher Scientific, USA), and U6 or GAPDH served as an internal control. Our results were analyzed using 2 -ΔΔCT method. 
Flow cytometry
For cell cycle analysis, the cells were fixed with 70% ethanol and resuspended in PBS. Afterward, 50 μg/ml propidium iodide (PI) and 0.2% Triton X-100 were added to the cells, incubated for another 30 min at 4 °C, and detected with a flow cytometer (BD Biosciences, NJ, USA). The distribution of cells in G0/G1, S, and G2/M phases was established using ModFit LT (Verity Software House).
For viability analyses, the cells were trypsinized, suspended in PBS, and stained with FITC Annexin V (1:500) for 15 min at room temperature. Before analyses were conducted, 4 μg/ml PI was added to the cells and analyzed with a flow cytometer.
Cell Counting Kit-8 (CCK8 assay)
CCK8 assay was conducted in accordance with the manufacturer's instructions (WST-8, Dojindi Labs, Kumamoto, Japan). In brief, A172 and U251 cells were seeded at a density of 3000 cells/well in a 96-well plate and treated with ethanol. After 24, 48, 72, and 96 h, 10 μl of CCK8 solution was added to each well of the plate, and the wells were incubated for 2 h. Absorbance at 450 nm was evaluated using a Multiscan MS spectrophotometer (Labsystems, Stockholm, Sweden).
Colony formation assay
In this procedure, 500 cells in the logarithmic growth phase were plated into Petri dishes with 10 ml of the culture medium. The cells were grown for 2 weeks at 37 °C, 5% CO 2 , and 100% humidity without changing the medium. Afterward, the cells were fixed with 4% paraformaldehyde and stained with Giemsa for 30 min, and colonies were counted under a microscope.
In vivo assays BALB/c nude mice were purchased from Shanghai Slac Laboratory Animal Co., Ltd. and maintained under SPF conditions. All of the animals were used in accordance with institutional guidelines, and our experiments were approved by the Use Committee for Animal Care of The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University. For tumor growth in vivo, 1 × 10 7 U251 cells were implanted subcutaneously in the flanks of BALB/c nude mice (six animals/each group). The mice were checked regularly for tumor size at the indicated time points. The tumor-bearing mice were sacrificed 5 weeks postimplantation, and tumor weights were measured. Cell proliferation and apoptosis in tumor tissues were analyzed through Western blot. For glioblastoma cell metastasis assays, 1 × 10 7 U251 cells were resuspended in PBS and injected into the tail vein of BALB/c nude mice. All of the mice were killed with CO 2 25 days after injection. Metastatic nodules in the lung tissues were quantified as previously described [23] .
Transwell assays
In this procedure, 48 h after transfection, 1 × 10 4 cells in serum-free DMEM were plated in the upper chamber (coated without 50 mg/l Matrigel for migration and with matrigel for invasion assay), while 600 μl of the full medium was placed in the lower chamber. The remaining cells on the upper surface were removed 24 h after incubation, and migrating or invading cells were fixed with 4% formaldehyde and stained with 0.1% crystal violet. For each experiment, 10 fields of view were counted, and the experiments were conducted at least three times.
Luciferase assays
The 3'-UTR target sites of the predicted target gene and a mutant variant were synthesized and cloned in the pmirGLO Dual-Luciferase miRNA target expression vector. A172 and U251 cells were seeded in 96-well plates and co-transfected 12 h later with plasmids (0.2 mg), miR-758-5p mimics (5 pmol) or scramble sequences (5 pmol) using Lipofectamine 2000 (Invitrogen, USA). The cells were harvested 48 h after transfection, and firefly and renilla luciferase activities were analyzed with the Dual-Luciferase™ Reporter Assay System, according to the manufacturer's instructions (Promega, USA).
Western blotting
Cells and tumor samples were homogenized with RIPA lysis buffer, and 50ug of the whole-cell lysates were separated by SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The membrane was then blocked with 5% non-fat dry milk in TBST for 1h, and then probed with indicated antibodies Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry overnight at 4°C. HRP conjugated goat anti-rabbit or anti-mouse secondary antibodies were cultured for another hour, and enhanced chemiluminescence reagents (ECL, Amersham Bioscience) were used to visualize the bands. ACTB was used as a loading control.
Statistical analyses
Statistical analysis was performed using the Student's t-test or one-way analysis of variance followed by Fisher's least significant difference post hoc test for multiple comparisons. Results are shown as mean ± SD. P<0.05 was considered statistically significant.
Results
miR-758-5p was downregulated in GBM
All of the differentially expressed miRNAs in Gulluoglu's cohort (GSE90604) were analyzed (Fig. 1A) to explore the functions of miRNAs in GBM. Among the 21 differentially expressed miRNAs, miR-758-5p was the most significantly downregulated (Figs. 1A and B) . The miR-758-5p expression in GBM tumor tissues (n = 55) and adjacent normal tissues (n = 55) was analyzed through qRT-PCR to confirm that miR-758-5p was downregulated in GBM. Our results verified that miR-758-5p was downregulated in GBM tissues compared with that in adjacent normal tissues (Fig. 1C) . The miR-758-5p expression decreased as the TNM stages of GBM tissues advanced (Fig. 1D) . The miR-758-5p expression levels were also downregulated in all of the GBM cell lines compared with those in the normal control cell line (HEB; Fig. 1E ). A high miR-758-5p expression was correlated with a high survival rate of patients with GBM (Fig. 1F) . These results showed that miR-758-5p was downregulated in GBM. Thus, miR-758-5p might suppress GBM progression.
Upregulation of miR-758-5p suppressed GBM cell proliferation and promoted apoptosis
Altered proliferation and apoptosis are two key characters that distinguish tumor cells from normal cells [24] . In our study, miR-758-5p was overexpressed in A172 and U251 GBM cell lines to examine the function of miR-758-5p in GBM proliferation and apoptosis ( Fig. 2A) . CCK8 assays showed that the miR-188-5p overexpression significantly inhibited GBM cell proliferation (Fig 2B) . Consistent with this finding, our results revealed that the colony formation ability of the GBM cells was greatly reduced when miR-758-5p (Figs. 2C) , indicating that miR-758-5p inhibited GBM cell proliferation. FACS was conducted to analyze the cell cycle distribution and to further evaluate the proliferation of GBM cells after miR-758-5p was overexpressed. The results showed that the miR-758-5p overexpression blocked the progression of the GBM cell cycle. When miR-758-5p was overexpressed, the number of cells in the G0/G1 and G2/M phases increased, whereas the number of cells in the S phase decreased (Fig. 2D) . At the same time, the number of Annexin V-positive cells increased (Fig. 2E) , indicating that miR-758-5p induced the apoptosis of GBM cells. Xenograft experiments also demonstrated that tumor size and volume were significantly reduced when miR-758-5p was overexpressed (Figs. 2F and G) . More apoptotic cells were found as indicated by more cleaved caspase3 and more apoptotic cells (Fig. 2H) . These results showed that miR-758-5p inhibited GBM progression, and miR-758-5p might function as a tumor suppressor of GBM.
miR-758-5p inhibited the migration and invasion of GBM cells
To gain malignant phenotypes, tumor cells must develop their migration and invasion ability. In our study, Transwell assays were performed to analyze the migration and invasion of the GBM cells after miR-758-5p was overexpressed and to further examine the role of miR-758-5p in tumor migration and invasion. The results showed that the migration and invasion of the GBM cells were significantly reduced after miR-758-5p was overexpressed (Figs. 3A and B) . The expression of mesenchymal marker genes decreased, whereas the expression of the metastasis-related genes α-catenin and E-cadherin increased (Fig. 3C) . In vivo metastasis assays also revealed few metastatic nodules in the lungs after miR-758-5p was overexpressed (Fig. 3D) . These results indicated that miR-758-5p inhibited the invasion 
miR-758-5p regulated ZBTB20 expression
The gene of miRNA modules is expressed by binding to the 3ʹUTR of mRNA [25] . To reveal the mechanism of miR-758-5p in the regulation of GBM, we predicted the possible binding partner of miR-758-5p. We found that miR-758-5p might bind to the 3ʹUTR of ZBTB20 (Fig.  4A) . miR-758-5p mimic transfection inhibited the ZBTB20 expression (Fig.  4B) . When the possible binding sites were mutated, the inhibitory effect was completely rescued (Fig.  4C) . These results suggested that miR-758-5p bound to 3ʹUTR and inhibited the ZBTB20 expression. qRT-PCR results also showed that ZBTB20 expression was downregulated in the GBM cell lines when miR-758-5p was overexpressed (Fig.  4C ) but was upregulated when miR-758-5p was inhibited by a neutralizing antibody (Fig. 4D) . Western blot further confirmed that miR-758-5p overexpression inhibited the ZBTB20 expression (Fig. 4E) . qRT-PCR analysis also demonstrated a negative correlation between miR-758-5p and ZBTB20 expression (Fig.  4F) . These findings were consistent with previously published data. Therefore, miR-758-5p bound to the 3ʹUTR of ZBTB20 and inhibited its expression.
ZBTB20 promoted GBM progression
Considering that miR-758-5p regulated the ZBTB20 expression, we further determined the function of ZBTB20 in GBM progression. Expression analysis from public databases showed that 
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ZBTB20 was significantly overexpressed in the GBM tissues compared with that in the normal tissues (Figs. 5A and B) . The ZBTB20 expression in 9 normal tissues and 16 GBM tissues was analyzed to further confirm that ZBTB20 was overexpressed in the GBM tissues. Our results revealed that ZBTB20 was overexpressed compared with that in the normal control (Fig. 5C ), and this observation was consistent with that obtained through our database analysis. The ZBTB20 expression was also higher in the GBM cell lines than in the normal control (Fig. 5D) .
To verify the function of ZBTB20 in GBM progression, we conducted functional assays after ZBTB20 was knocked down (Fig. 5E) . We found that ZBTB20 knockdown inhibited GBM cell proliferation (Figs. 5F and G) . The ZBTB20 knockdown also promoted GBM cell apoptosis (Fig. 5H ). Invasion and migration assays also demonstrated that ZBTB20 knockdown inhibited GBM cell invasion and migration (Figs. 5I and J). These results suggested that ZBTB20 promoted GBM progression.
miR-758-5p suppressed GBM progression through ZBTB20
Considering that miR-758-5p suppressed GBM progression, ZBTB20 promoted GBM progression, and miR-758-5p bound to the 3ʹUTR of ZBTB20, we hypothesized that miR-758-5p suppressed GBM progression through ZBTB20. To validate this hypothesis, we restored the ZBTB20 expression in miR-758-5p-overexpressing GBM cells (Fig. 6A) and analyzed the phenotypes. Proliferation assays revealed that ZBTB20 restoration rescued the inhibitory effect of miR-758-5p overexpression on GBM growth (Fig. 6B) . Colony formation assays demonstrated that numerous colonies were generated (Fig. 6C) , and the resistance of the cells to apoptosis increased (Fig. 6D) . The invasion and migration abilities were also rescued after ZBTB20 expression was restored (Figs. 6E and F) . These data indicated that miR-758-5p suppressed GBM progression through ZBTB20. 
Discussion
Although studies have shown that miRNAs play an essential role in tumor progression [26] , studies have yet to reveal the function of miR-758-5p in cancer. Other studies have demonstrated that miR-758-5p expression is altered in cancer, but research has yet to identify the function of miR-758-5p in cancer [21, 22] . Besides, the importance of miRNAs in GBM has been emphasized by increasing evidences. For example, miR-595 could promote GBM cell proliferation via targeting SOX7 [27] . miR-181b is reported to be implicated in GBM progression [28] . In our study, we examined the function of miR-758-5p in GBM and identified for the first time that miR-758-5p acted as a tumor suppressor gene in GBM.
Our unbiased microarray analysis demonstrated that miR-758-5p was significantly downregulated in GBM tissues, and the survival time was relatively short, indicating a possible suppressor role of miR-758-5p in GBM. Unlimited proliferation, invasion, and migration are hallmarks and characteristics of cancer [29] . Through CCK8, FACS and transwell assays, we demonstrated that miR-758-5p overexpression suppressed GBM cell proliferation, migration and invasion while promoting apoptosis, indicating a tumor suppressor role of miR-758-5p in GBM.
In a classical way of gene expression regulation, miRNAs bind to the 3ʹUTR of target mRNAs to regulate target gene expression [7] . Through binding partner predication, we found the possible interaction between miR-758-5p and the 3ʹUTR of ZBTB20 and validated their binding through mutation analysis. miR-758-5p had a negative co-expression relationship with ZBTB20, and miR-758-5p overexpression likely led to a decrease in ZBTB20 expression. Thus, ZBTB20 might be a functional target of miR-758-5p in GBM. ZBTB20, as a zinc finger protein, has been implicated in glucose and lipid homoeostasis [30, 31] and in the tumor progression of hepatocellular carcinoma [32] , indicating a role in cancer. In our study, ZBTB20 was overexpressed in GBM, and ZBTB20 knockdown suppressed GBM progression. This finding suggested that ZBTB20 served as a tumor progression gene. Further analysis showed that miR-758-5p suppressed GBM progression through ZBTB20 because ZBTB20 overexpression in GBM cells would rescue the malignant progression phenotypes of GBM. These results indicated that miR-758-5p and ZBTB20 axis 
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Cellular Physiology and Biochemistry participated in GBM progression. miR-758-5p was downregulated in GBM, whereas ZBTB20 was upregulated in GBM. However, there are still some limitations in our study. Firstly, the upstream regulatory mechanism of miR-758-5p expression requires to be investigated in the future. Secondly, we know there are a lot of predicted targets of miR-758-5p. Whether other target genes are also involved in the role of miR-758-5p remain largely unknown. Finally, how ZBTB20 exerts roles in GBM progression needs more experiments.
Conclusion
In this study, we demonstrated for the first time that miR-758-5p functions as a tumor suppressor gene, and the role of ZBTB20 in GBM progression. We found that miR-758-5p suppresses GBM progression, while ZBTB20 promotes GBM progression, and miR-758-5p suppresses GBM through ZBTB20. Yet, we still do not know how ZBTB20 promotes GBM progression, and this needs to be further studied.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
